C.J. Twelves

Pharmacoeconomic analysis of adjuvant oral capecitabine vs intravenous 5-FU/LV in Dukes' C colon cancer: the X-ACT trial

J Cassidy, J.-Y. Douillard, C.J. Twelves et al. · British Journal of Cancer · 2006 · 124 citations · Full text

The response of cerebral metastases in small cell lung cancer to systemic chemotherapy

C.J. Twelves, R L Souhami, PG Harper et al. · British Journal of Cancer · 1990 · 104 citations · Full text

Neuro-oncology, Cerebral Metastases, Tumor Innervation +7

A phase I and pharmacokinetic study of LY231514, the multitargeted antifolate.

A. McDonald, P. Vasey, Lynn Adams et al. · PubMed · 1998 · 84 citations

Pharmaceutical Science, Pharmacokinetic Study, Pharmacotherapy +17

Capecitabine (X) vs bolus 5-FU/leucovorin (LV) as adjuvant therapy for colon cancer (the X-ACT study): positive efficacy results of a phase III trial

Jim Cassidy, Werner Scheithauer, J. McKendrick et al. · Journal of Clinical Oncology · 2004 · 74 citations

Surgical Oncology, Cancer Management, Pharmacotherapy +17

A phase II, multicentre, UK study of vinorelbine in advanced breast cancer

C.J. Twelves, N Dobbs, Alison Curnow et al. · British Journal of Cancer · 1994 · 72 citations

Advanced Breast Cancer, Breast Oncology, Phase Ii +11